✦ LIBER ✦

8 ALIPOGENE TIPARVOVEC GENE THERAPY ENHANCES POST-PRANDIAL CLEARANCE OF CHYLOMICRONS IN LIPOPROTEIN LIPASE DEFICIENT PATIENTS

✍ Scribed by Carpentier, A.C.; Frisch, F.; Labbé, S.M.; Méthot, J.; Gagné, C.; Déry, S.; Tremblay, K.; de Wal, J.; Twisk, J.; Greentree, S.; van den Bulk, N.; Brisson, D.; Gaudet, D.

Book ID: 118639015
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 43 KB
Volume: 12
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(11)70009-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene Therapy With Alipogene Tiparvovec R

Gene Therapy With Alipogene Tiparvovec Results in Enhanced Post-prandial Clearance of Chylomicrons in LPLD Patients

✍ Gaudet, D.; Frisch, F.; Méthot, J.; Gagné, C.; Déry, S.; Tremblay, K.; de Wal, J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

35 ALIPOGENE TIPARVOVEC GENE THERAPY SIG

35 ALIPOGENE TIPARVOVEC GENE THERAPY SIGNIFICANTLY REDUCES THE RISK OF PANCREATITIS IN LIPOPROTEIN LIPASE DEFICIENT PATIENTS

✍ Greentree, S.; Méthot, J.; Déry, S.; Tremblay, K.; de Wal, J.; van den Bulk, N.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

557 Alipogene Tiparvovec Gene Therapy Re

557 Alipogene Tiparvovec Gene Therapy Reduces the Risk of Acute Pancreatitis in Patients With Lipoprotein Lipase Deficiency

✍ Marco J. Bruno; Mark Deakin; Philippe B. Ruszniewski; Nick V. Bulk; Janneke de W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Pancreatitis in patients with lipoprotei

Pancreatitis in patients with lipoprotein lipase deficiency and the effect of alipogene tiparvovec (AAV1-LPLS447X gene therapy)

✍ Deakin, M.; De Wal, J.; Camozzi, C.; Bruno, M.; Ruszniewski, P.; Gaudet, D. 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 48 KB

L7 RESULTS OF FIRST FOLLOW UP STUDY WITH

L7 RESULTS OF FIRST FOLLOW UP STUDY WITH GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) IN LIPOPROTEIN LIPASE DEFICIENCY (LPLD)

✍ Gaudet, D.; de Wal, J.; Brisson, D.; van den Bulk, N.; Greentree, S.; Méthot, J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Abstract: 554 AN OPEN-LABEL, DOSE ESCALA

Abstract: 554 AN OPEN-LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF AAV1-LPLS447X GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) FOR PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA DUE TO LIPOPROTEIN LIPASE DEFICIENCY (LPLD)

✍ Gaudet, D; Brisson, D; Methot, J; van Deventer, S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 76 KB